EcoDrugPlus

Ret Proto-Oncogene Receptor Tyrosine Kinase

Ensembl ID : ENSORLG00000013965
Gene Symbol: RET
4 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSORLG00000016394
Gene Symbol: LOC101155959
3 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSORLG00000008502
Gene Symbol: RARB
4 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Gamma A

Ensembl ID : ENSORLG00000007861
Gene Symbol: RARGA
3 Cross references
325 Possible Orthologues:

Retinoic Acid Receptor Gamma-A

Ensembl ID : ENSORLG00000015382
Gene Symbol: LOC100125516
4 Cross references
373 Possible Orthologues:

Retinoid X Receptor, Alpha A

Ensembl ID : ENSORLG00000012155
Gene Symbol: RXRAA
4 Cross references
225 Possible Orthologues:

Retinoid X Receptor, Beta B

Ensembl ID : ENSORLG00000007020
Gene Symbol: RXRBB
4 Cross references
211 Possible Orthologues:

Rho-Associated Protein Kinase 2

Ensembl ID : ENSORLG00000012731
Gene Symbol: LOC101159717
4 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSORLG00000018255
Gene Symbol: ROCK2A
4 Cross references
225 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSORLG00000027642
Gene Symbol: RPL10
4 Cross references
408 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSORLG00000006600
Gene Symbol: RPL10A
4 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSORLG00000007578
Gene Symbol: RPL11
4 Cross references
288 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).